Dr. Reddy’s Lab’s Q4FY22 Quarter Results
Dr. Reddy’s Lab’s net revenues grew 15.4% YoY in Q4FY22.
- 19 May 2022
- Dr. Reddy’s Lab’s consolidated revenues for the quarter ended March (Q4FY22) were up 3.8% quarter-on-quarter (QoQ). On a year-on-year (YoY) basis, it witnessed a growth of 15.4%.
- Its expenses for the quarter were up 20.5% QoQ and 31.9% YoY.
- The earnings per share (EPS) of Dr. Reddy’s Lab stood at 5.8 during Q4FY22.
Dr. Reddy’s Lab’s Financial Statements for Q4FY22:
Total Income | 4,851 | 5,394 | 5,597 | 3.8% | 15.4% |
Total Expenses | 4,054 | 4,438 | 5,348 | 20.5% | 31.9% |
Profit before tax | 815 | 974 | 259 | -73.4% | -68.2% |
Tax | 258 | 265 | 162 | -38.9% | -37.2% |
Profit after tax | 557 | 709 | 97 | -86.3% | -82.6% |
Earnings per share | 33.5 | 42.7 | 5.8 |
Data Source: BSE, Company announcements
Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Open Demat Account
Open Demat Account